Latest updates for Albumin Fusion

Fresh curated links around Albumin fusion are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Albumin fusion for hemophilia
  • Albumin-Fused Antibodies May Reduce Fetal Exposure to Therapeutics
  • Companies join forces to commercialize proposed biosimilar

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

hemophilianewstoday.com /1 week ago

Albumin fusion for hemophilia

Albumin fusion is a molecular technology that has been used to create replacement therapies for hemophilia with an extended half-life — treatments that are more long-lasting in the...

Read source
genengnews.com /3 weeks ago

Albumin-Fused Antibodies May Reduce Fetal Exposure to Therapeutics

Preclinical study found that fusing immunoglobulin G (IgG) antibodies to albumin minimized antibody transport across the placenta and prevented adverse effects in offspring in mice...

Read source
hemophilianewstoday.com /1 week ago

Companies join forces to commercialize proposed biosimilar

Alvotech and Lotus Pharmaceutical are teaming up on plans to commercialize AVT87, a proposed biosimilar to Hemlibra (emicizumab). Lisa Graver, CEO of Alvotech, said in a company pr...

Read source
fiercebiotech.com /3 weeks ago

Tolerance Bio jumps into phase 2 with $260M deal for thymus-targeting fusion protein

Tolerance Bio has vaulted into the clinic by agreeing to pay NeoImmuneTech up to $260 million for rights to a fusion protein in certain thymus-related indications in the Americas a...

Read source
hemophilianewstoday.com /2 weeks ago

Obizur (susoctocog alfa) for hemophilia

Obizur (susoctocog alfa) is a recombinant porcine (pig-derived) factor VIII concentrate approved for the on-demand treatment of bleeds in adults with acquired hemophilia A. The pos...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Albumin Fusion

feeds.feedburner.com

Recent coverage from public sources
Public source

hemophilianewstoday.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source